{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:58:24Z","timestamp":1790931504016,"version":"4.1.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1097\/jcp.0b013e3181602fe6","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T06:33:54Z","timestamp":1236234834000},"page":"27-31","source":"Crossref","is-referenced-by-count":55,"title":["Predictors of Antipsychotic-Induced Weight Gain in First-Episode Psychosis"],"prefix":"10.1097","volume":"28","author":[{"given":"Sahoo","family":"Saddichha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahul","family":"Ameen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayeed","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/schbul\/22.2.271","article-title":"Early detection and intervention for initial episodes of schizophrenia.","volume":"22","author":"Falloon","year":"1996","journal-title":"Schizophr Bull"},{"key":"R2-5-20210128","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1034\/j.1600-0447.2002.02376.x","article-title":"One-year outcome in first episode psychosis patients in the Swedish parachute project.","volume":"106","author":"Cullberg","year":"2002","journal-title":"Acta Psychiatr Scand"},{"issue":"3-4","key":"R3-5-20210128","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-3956(97)00012-5","article-title":"Course of psychopathology, cognition and neurobiological abnormality in schizophrenia: developmental origins and amelioration by antipsychotics?","volume":"32","author":"Waddington","year":"1998","journal-title":"J Psychiatr Res"},{"issue":"3-4","key":"R4-5-20210128","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0022-3956(98)00008-9","article-title":"Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness.","volume":"32","author":"Haas","year":"1998","journal-title":"J Psychiatr Res"},{"issue":"33","key":"R5-5-20210128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1192\/S0007125000297663","article-title":"Early intervention in psychosis: the critical period hypothesis.","volume":"S172","author":"Birchwood","year":"1998","journal-title":"Br J Psychiatry"},{"key":"R6-5-20210128","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/schbul\/23.4.653","article-title":"The evaluation and treatment of first-episode psychoses.","volume":"23","author":"Sheitman","year":"1997","journal-title":"Schizophr Bull"},{"key":"R7-5-20210128","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1176\/ajp.156.4.544","article-title":"Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder.","volume":"156","author":"Robinson","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R8-5-20210128","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/schbul\/18.2.273","article-title":"The McLean first-episode psychosis project: six-month recovery and recurrence outcome.","volume":"18","author":"Tohen","year":"1992","journal-title":"Schizophr Bull"},{"key":"R9-5-20210128","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpsyc.56.3.241","article-title":"Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.","volume":"56","author":"Robinson","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"R10-5-20210128","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.158.11.1835","article-title":"Clinical outcome following neuroleptic discontinuation in patients with remitted recent onset schizophrenia.","volume":"158","author":"Gitlin","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R11-5-20210128","first-page":"272","article-title":"Weight gain in first-episode psychosis. Can. J.","volume":"48","author":"Addington","year":"2003","journal-title":"Psychiatry"},{"key":"R13-5-20210128","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1176\/appi.ps.54.4.565","article-title":"The impact of weight gain on quality of life among patients with schizophrenia.","volume":"54","author":"Allison","year":"2003","journal-title":"Psychiatr Serv"},{"key":"R14-5-20210128","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1056\/NEJM199003293221303","article-title":"A prospective study of obesity and risk of coronary heart disease in women.","volume":"322","author":"Manson","year":"1990","journal-title":"N Eng J Med"},{"issue":"suppl 7","key":"R15-5-20210128","first-page":"22","article-title":"Antipsychotic-induced weight gain: a review of the literature.","volume":"62","author":"Allison","year":"2001","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"R16-5-20210128","first-page":"626","article-title":"Naturalistic impact of second-generation antipsychotics on weight gain.","volume":"40","author":"Brixner","year":"2006","journal-title":"Ann Pharm"},{"issue":"suppl 6","key":"R17-5-20210128","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/0269881105058378","article-title":"Weight change with atypical antipsychotics in the treatment of schizophrenia.","volume":"19","author":"Haddad","year":"2005","journal-title":"J Psychopharmacol"},{"key":"R18-5-20210128","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1176\/appi.ajp.160.8.1396","article-title":"Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.","volume":"160","author":"Lieberman","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R19-5-20210128","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.schres.2006.06.021","article-title":"Olanzapine and haloperidol in first episode psychosis: two-year data.","volume":"86","author":"Green","year":"2006","journal-title":"Schizophrenia Research"},{"key":"R20-5-20210128","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1176\/appi.ajp.162.1.118","article-title":"Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis.","volume":"162","author":"Graham","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R21-5-20210128","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1176\/appi.ajp.162.5.947","article-title":"Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.","volume":"162","author":"Schooler","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R22-5-20210128","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.schres.2006.06.035","article-title":"Weight gain in first-episode psychosis over three years.","volume":"86","author":"Addington","year":"2006","journal-title":"Schizophrenia Res"},{"key":"R23-5-20210128","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.schres.2005.07.024","article-title":"Weight gain and lipid metabolic abnormalities induced by olanzapine in first-episode, drug-naive patients with psychotic disorders.","volume":"80","author":"Sengupta","year":"2005","journal-title":"Schizophrenia Res"},{"key":"R24-5-20210128","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.schres.2007.02.024","article-title":"Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.","volume":"93","author":"Strassnig","year":"2007","journal-title":"Schizophrenia Res"},{"issue":"suppl 21","key":"R26-5-20210128","first-page":"16","article-title":"Weight gain associated with use of psychotropic medications.","volume":"60","author":"Sachs","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R27-5-20210128","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body mass index for Asian population and its implications for policy and interventional strategies.","volume":"363","year":"2004","journal-title":"Lancet"},{"issue":"11","key":"R28-5-20210128","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.4088\/JCP.v68n1120","article-title":"Effect of olanzapine, risperidone and haloperidol treatment on weight and BMI in first-episode schizophrenia patients in India: a randomized double blind controlled prospective study.","volume":"68","author":"Saddichha","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"suppl 7","key":"R30-5-20210128","first-page":"11","article-title":"Antipsychotic-associated weight gain and clinical outcome parameters.","volume":"62","author":"Blin","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R31-5-20210128","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1192\/bjp.187.6.537","article-title":"Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol.","volume":"187","author":"Zipursky","year":"2005","journal-title":"Br J Psychiatry"},{"issue":"suppl 47","key":"R32-5-20210128","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1192\/bjp.184.47.s76","article-title":"Metabolic disturbance in first-episode schizophrenia.","volume":"184","author":"Thakore","year":"2004","journal-title":"Br J Psychiatry"},{"key":"R33-5-20210128","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1192\/bjp.155.6.777","article-title":"Physical health of the long-term mentally ill in the community: is there unmet need?","volume":"155","author":"Brugha","year":"1989","journal-title":"Br J Psychiatry"},{"key":"R34-5-20210128","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1192\/bjp.169.6.733","article-title":"Cardiovascular and respiratory risk factors and symptoms among general practice patients with long-term mental illness.","volume":"169","author":"Kendrick","year":"1996","journal-title":"Br J Psychiatry"},{"key":"R35-5-20210128","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.ijo.0801840","article-title":"Increased visceral fat distribution in drug-naive and drug free patients with schizophrenia.","volume":"26","author":"Thakore","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R36-5-20210128","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first episode, drug-naive patients with schizophrenia.","volume":"160","author":"Ryan","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"suppl 47","key":"R37-5-20210128","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1192\/bjp.184.47.s102","article-title":"Diet, diabetes and schizophrenia: review and hypothesis.","volume":"184","author":"Peet","year":"2004","journal-title":"Br J Psychiatry"},{"key":"R38-5-20210128","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.jcp.0000130558.86125.5b","article-title":"A comparison of risperidone-induced weight gain across the age span.","volume":"24","author":"Safer","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"R39-5-20210128","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/00023210-200115070-00004","article-title":"Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications.","volume":"15","author":"Russell","year":"2001","journal-title":"CNS Drugs"},{"issue":"3","key":"R40-5-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0920-9964(01)00256-0","article-title":"Changes in body mass index for individuals with and without schizophrenia, 1987-1996.","volume":"55","author":"Homel","year":"2002","journal-title":"Schizophr Res"},{"key":"R41-5-20210128","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/S0033291798008186","article-title":"The unhealthy lifestyle of people with schizophrenia.","volume":"29","author":"Brown","year":"1999","journal-title":"Psychol Med"},{"key":"R42-5-20210128","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/schbul\/11.3.471","article-title":"The two syndrome concept: origins and current status.","volume":"11","author":"Crow","year":"1985","journal-title":"Schizophrenia Bull"},{"issue":"2","key":"R43-5-20210128","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00127-006-0135-2","article-title":"Physical illness and lifestyle risk factors in people with their first presentation of psychosis.","volume":"42","author":"Samele","year":"2007","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"R44-5-20210128","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/bmj.322.7299.1406","article-title":"Obesity.","volume":"322","author":"Arterburn","year":"2001","journal-title":"BMJ"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-200802000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T03:01:29Z","timestamp":1710126089000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-200802000-00005"}},"subtitle":["Conclusions From a Randomized, Double-Blind, Controlled Prospective Study of Olanzapine, Risperidone, and Haloperidol"],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181602fe6","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}